ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8:30 a.m. ET
February 07 2024 - 6:50AM
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP)
today announced that the Company will release its fourth quarter
and full year 2023 financial results on Thursday, February 29,
2024, prior to the market open.
Nikhil Lalwani, President and Chief Executive
Officer, and Stephen P. Carey, Senior Vice President, Finance, and
Chief Financial Officer, will host a conference call to discuss the
results as follows:
Date |
|
Thursday,
February 29, 2024 |
|
|
|
Time |
|
8:30 a.m. ET |
|
|
|
Toll free (U.S.) |
|
800-274-8461 |
|
|
|
Webcast (live and replay) |
|
www.anipharmaceuticals.com, under the “Investors” section |
|
|
|
A replay of the conference call will be available within two
hours of the call’s completion and will remain accessible for two
weeks by dialing 800-839-8531 and entering access code 4470257.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified
biopharmaceutical company serving patients in need by developing,
manufacturing, and marketing high quality branded and generic
prescription pharmaceutical products, including for diseases with
high unmet medical need. Our team is focused on delivering
sustainable growth by scaling up our Rare Disease business through
the successful launch of our lead asset, Purified Cortrophin® Gel,
strengthening our generics business with enhanced research and
development capability, innovation in established brands and
leveraging our North American manufacturing capabilities. For more
information, please visit our
website www.anipharmaceuticals.com.
Investor Relations Contact:Lisa M. Wilson,
In-Site Communications, Inc.212-452-2793lwilson@insitecony.com
SOURCE: ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Apr 2024 to May 2024
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From May 2023 to May 2024